Rankings
▼
Calendar
MNOV Q2 2025 Earnings — MediciNova, Inc. Revenue & Financial Results | Market Cap Arena
MNOV
MediciNova, Inc.
$69M
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$134,599
Gross Profit
$18,250
13.6% margin
Operating Income
-$4M
-2679.9% margin
Net Income
-$3M
-2437.7% margin
EPS (Diluted)
$-0.07
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$204,897
Balance Sheet
Total Assets
$50M
Total Liabilities
$3M
Stockholders' Equity
$47M
Cash & Equivalents
$34M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$134,599
$0
—
Gross Profit
$18,250
$0
—
Operating Income
-$4M
-$3M
-18.4%
Net Income
-$3M
-$3M
-24.8%
← FY 2025
All Quarters
Q3 2025 →